#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Marginal zone lymphoma refractory Endometrial adenocarcinoma Aspergillus infection Acquired ATTR amyloidosis Partial lipodystrophy Medullary thyroid cancer Metachromatic leukodystrophy Fusarium infection Glomerulonephritis minimal lesion Thrombocytopenia Hyperinsulinaemic hypoglycaemia Mantle cell lymphoma stage II Asthma Tourette's disorder Paroxysmal nocturnal haemoglobinuria More trials…

    Learn about Rare Diseases

    Angiosarcoma non-metastatic – Basic Information Langerhans cell sarcoma – Life with Disease Langerhans’ cell histiocytosis – Treatment Congenital nephrogenic diabetes insipidus – Trials in Disease Andersen-Tawil syndrome – Basic Information Angiosarcoma metastatic – Treatment Marfan’s syndrome KBG syndrome – Life with Disease Angiosarcoma Nodal marginal zone B-cell lymphoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pemetrexed Diacid Monohydrate ANX007 Pitolisant Purified Egg Phospholipids Floxuridine Nms-03592088 Minzasolmin Defactinib VERCIRNON Hydrocortisone Oxytocin Ht-29-B Ezetimibe Eplontersen Sym025 Crinecerfont Ambrosia Artemisiifolia (302) Follitropin Alfa Oms906 Ataluren More therapies…

    Learn about Your Condition

    Substance use disorder Incisional hernia Head and neck cancer Still's disease Carcinoid tumour pulmonary Combined immunodeficiency Chronic hepatitis B Muscle spasticity Pyelonephritis acute Myelofibrosis Gastrooesophageal cancer Malignant melanoma stage III Invasive breast carcinoma Lymphocytic leukaemia Cardiac disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on Triamcinolone Acetonide Injections to Prevent Esophageal Strictures in Children with Esophageal Atresia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Oesophageal atresia
    Investigated Drugs:
    • Triamcinolone Acetonide
    Denmark Finland France The Netherlands Sweden

  • Study on the Effect of Arginine-Vasopressin and Noradrenaline Tartrate on Acute Kidney Injury in Liver Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute kidney injury
    • Liver transplant
    Investigated Drugs:
    • Argipressin
    • Noradrenaline Tartrate
    France

  • Study on the Safety and Feasibility of Bevacizumab-800CW Imaging for Patients with Barrett’s Esophagus, Colon Cancer, or Gastrointestinal Dysplasia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Barrett’s oesophagus
    • Colon cancer
    Investigated Drugs:
    • Bevacizumab
    The Netherlands

  • Study on Preventing Crohn’s Disease Recurrence After Surgery Using Risankizumab and Drug Combination in Adults at Risk

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Vedolizumab
    • Mirikizumab
    • Adalimumab
    Belgium Italy

  • Study on UCPVax, Atezolizumab, and Bevacizumab for Patients with Unresectable Liver Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Ucp4
    • Bevacizumab
    • Atezolizumab
    France

  • Study on Hilar Cholangiocarcinoma Treatment Using Porfimer Sodium and Foscan for Patients with Bile Duct Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Germany
Previous Page
1 … 38 39 40 41 42 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!